Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
4
pubmed:dateCreated
1985-7-17
pubmed:abstractText
The tubular disposition of five aminoglycosides was studied in humans to establish a possible relationship between tubular reabsorption and the nephrotoxicity that has been described in the literature. Thirty-three healthy male volunteers received a continuous intravenous infusion of isotonic saline with inulin, followed 1 h later by inulin plus gentamicin, dibekacin, tobramycin, netilmicin, or amikacin (1 mg/kg per h) or amikacin (4 mg/kg per h) over a period of 2 h. Brain-stem-evoked response audiometry was performed both before and at the end of each infusion. The latency of wave V remained constant whichever antibiotic was considered. The glomerular filtration rate did not vary significantly during the infusion of each drug. The percent fractional excretion was 79 +/- 6, 81 +/- 22, 85 +/- 5, and 99 +/- 9 for gentamicin, dibekacin, tobramycin, and netilmicin, respectively, and 83 +/- 4 and 124 +/- 13 for amikacin at concentrations of 1 and 4 mg/kg per h, respectively. Net balance and renal clearance were similar for the five aminoglycosides when administered at a rate of 1 mg/kg per h. With gentamicin only, fractional excretion was correlated with the urinary flow rate. We can conclude that (i) gentamicin, generally considered the most nephrotoxic agent, had the highest degree of net reabsorption; (ii) netilmicin exhibited a net zero tubular balance; (iii) amikacin had different patterns of tubular disposition according to the dose, i.e., reabsorption at 1 mg/kg per h and secretion at 4 mg/kg per h, raising the hypothesis of a saturable process of reabsorption; and (iv) these differences in tubular reabsorption could account at least in part for the known different nephrotoxic potentials of these five aminoglycosides in humans.
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/4004192-15430407, http://linkedlifedata.com/resource/pubmed/commentcorrection/4004192-319355, http://linkedlifedata.com/resource/pubmed/commentcorrection/4004192-4935296, http://linkedlifedata.com/resource/pubmed/commentcorrection/4004192-5356592, http://linkedlifedata.com/resource/pubmed/commentcorrection/4004192-6109786, http://linkedlifedata.com/resource/pubmed/commentcorrection/4004192-6312345, http://linkedlifedata.com/resource/pubmed/commentcorrection/4004192-6313902, http://linkedlifedata.com/resource/pubmed/commentcorrection/4004192-6364908, http://linkedlifedata.com/resource/pubmed/commentcorrection/4004192-6365881, http://linkedlifedata.com/resource/pubmed/commentcorrection/4004192-6365884, http://linkedlifedata.com/resource/pubmed/commentcorrection/4004192-6421944, http://linkedlifedata.com/resource/pubmed/commentcorrection/4004192-6482168, http://linkedlifedata.com/resource/pubmed/commentcorrection/4004192-6643334, http://linkedlifedata.com/resource/pubmed/commentcorrection/4004192-6694109, http://linkedlifedata.com/resource/pubmed/commentcorrection/4004192-6712201, http://linkedlifedata.com/resource/pubmed/commentcorrection/4004192-6951205, http://linkedlifedata.com/resource/pubmed/commentcorrection/4004192-6988713, http://linkedlifedata.com/resource/pubmed/commentcorrection/4004192-7018267, http://linkedlifedata.com/resource/pubmed/commentcorrection/4004192-7038007, http://linkedlifedata.com/resource/pubmed/commentcorrection/4004192-7155850, http://linkedlifedata.com/resource/pubmed/commentcorrection/4004192-7204294, http://linkedlifedata.com/resource/pubmed/commentcorrection/4004192-7205620, http://linkedlifedata.com/resource/pubmed/commentcorrection/4004192-7241882, http://linkedlifedata.com/resource/pubmed/commentcorrection/4004192-7325235, http://linkedlifedata.com/resource/pubmed/commentcorrection/4004192-7463954
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Apr
pubmed:issn
0066-4804
pubmed:author
pubmed:issnType
Print
pubmed:volume
27
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
520-4
pubmed:dateRevised
2009-11-18
pubmed:meshHeading
pubmed:year
1985
pubmed:articleTitle
Renal disposition of gentamicin, dibekacin, tobramycin, netilmicin, and amikacin in humans.
pubmed:publicationType
Journal Article, Comparative Study